Vertex Pharmaceuticals Incorporated (BIT:1VRTX)

Italy flag Italy · Delayed Price · Currency is EUR
328.55
0.00 (0.00%)
Last updated: Sep 24, 2025, 9:00 AM CET
Market Cap84.58B
Revenue (ttm)9.72B
Net Income (ttm)3.10B
Shares Outn/a
EPS (ttm)11.98
PE Ratio27.31
Forward PE19.75
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume16
Open328.55
Previous Close328.55
Day's Range328.55 - 328.55
52-Week Range316.00 - 487.60
Betan/a
RSI42.06
Earnings DateNov 3, 2025

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The com... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1989
Employees 6,100
Stock Exchange Borsa Italiana
Ticker Symbol 1VRTX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.